Amazon Honor System Click Here to Pay Learn More

     

Major Drug Database Page

Welcome to the Major Drug Database Page!

What is the Major Drug Database?

The Major Drug Database is a database that I first began working on in January of 2002 for stock/investment analysis purposes. It originally only contained the sales data for pharmaceutical products with over $400 million in annual revenues. Over the past year, the database has expanded to include patent expiration data, sales projections, and medical information. The database presently contains information on more than 360 pharmaceutical products from 33 pharmaceutical and biotech companies including:

  • Abbot Laboratories
  • Bristol-Myers-Squibb
  • Genentech
  • Merck
  • Schering-Plough
  • Akzo-Nobel - Organon
  • Celgene
  • Genzyme
  • Millennium
  • Scios
  • Allergan
  • Cephalon
  • Gilead Sciences
  • Novartis
  • Serono
  • Altana-Fougera
  • Chiron
  • GlaxoSmithKline
  • Pfizer
  • Shire
  • Amgen
  • Elan
  • Intermune
  • Pharmacia
  • Teva
  • AstraZeneca
  • Eli Lilly
  • Johnson & Johnson
  • QLT
  • The Medicines Company
  • Aventis
  • Enzon
  • King
  • Roche
  • UCB-Group
  • Bayer
  • Forest
  • Ligand
  • Sangstat
  • Wyeth
  • Biogen
  • Fujisawa
  • MedImmune
  • Sanofi-Synthelabo

As far as I know, this is the most comprehensive resource of its kind publicly and freely available on the Internet. I have included financial information for every single medically related product that I can find.

Site History/What's New

4/17/03
  • New feature: Added market share data for the Statin class of drugs over the past eight quarters with graphs showing the results. If I get good feedback over this, I will do something similar for the other major classes of drugs so write to me!
4/6/03
  • Major Drug Database Version 3.1 is now available.
  • Page has now been visited by more than 4000 people with over 10,000 page views. Thanks for coming!
2/27/03
  • Page has now received over 3300 visitors and more than 7600 page views.
11/27/02
  • New feature: Added a chart in the Market Share section comparing the effectiveness of the various pharmaceutical companies in converting marketing expenses into revenues.
11/26/02
  • Market share data section now has market share data on eleven different drug classes including the addition of angiotensin converting enzyme (ACE) inhibitors, anti-platelet agents, anti-histamines, thrombolytics/anti-coagulation agents, bisphosphonates, and multiple sclerosis drugs.
  • New update of the Major Drug Database coming soon with easier reading/printing format and the addition of more drugs including some from Organon and Altana.
11/20/02
  • Company profile and market share pages significantly expanded.
  • Split up the market share data into three separate pages (by global data, therapeutic area, and drug class) for easier viewing and better organization.
  • Page has now received over 1500 visitors and more than 3400 page views.
11/15/02
  • New feature:Added Flash navigation bar at the top of each page for easier navigation and for greater visibility of the secondary pages. Seems that most people weren't finding them.
  • New feature: Added a company profile page with overviews of the top pharmaceutical companies.
  • New feature: Added a links page. If you would like to be added as a link, please let EMAIL me.
11/12/02
  • New feature: Added an Frequently Asked Questions page.
  • New feature: Added a GuestMap so people can show everyone where they're visiting from.
  • Removed links to Major Drug Database versions 2.3 and 3.0. If you still want to see them, EMAIL me.
11/11/02
  • Received 1000th visitor. Thank you all for visiting!
11/10/02
  • New feature: Pharmaceutical Market Share Data is now available by geographical area, therapeutic area, and also by select drug class including statins, angiotensin II receptor blockers (ARB's), COX-2 inhibitors, proton pump inhibitors (PPI's), and selective serotonin reuptake inhibitors (SSRI's).
11/08/02
  • Major Drug Database Version 3.01 is now available.
  • New feature: Statin Price Comparison Chart available
11/05/02
  • Received 500th visitor. Data transfer limits at Geocities now exceeded on a daily basis. If you have problems accessing this site, please bookmark the URL and try at another time.
  • Added some Amazon links at the bottom of the page. Please consider using some of my links the next time you make a purchase at Amazon. There is no extra charge to you but a small portion of your sale will go towards the maintenance of this site.
11/02/02
  • Page completely redone in Microsoft FrontPage 2002. No more Geocities Java Webpage Builder.
11/01/02
  • Added links to PayPal and Amazon Honor System for those that wish to make donations to support this site. Thank you for your generosity and support in advance!
10/31/02
  • Major Drug Database Version 3.0 is now available. Received 100th visitor.
10/26/02
  • Page originally created after it was discovered that the Version 2.3 of the database did not fit on The Motley Fool message boards.

 

Major Drug Database Version History

Version 3.1 (4/06/03): 415 drugs, 44 companies, complete Q4 2002 and FY 2002 results.
- 48 more drugs and 13 more companies.
-
drug database now more readable spreaad across two pages with repeated column and row headings.

Version 3.01
(11/07/02): 367 drugs, 31 companies, even more Q3 2002 updates.
- 12 more drugs and 1 one more company afteer Elan was added to the database.
- Corrected a few errors in the worksheet.<
- Database is now available in SIX sorted vversions. Added a version that is sorted by predicted FY 2002 sales.

Version 3.0 (10/31/02): 355 drugs, 30 companies, more complete Q3 2002 results.
- 22 more drugs and 4 more companies after the addition of Chiron, Gilead Sciences, King, MedImmune to the database.
- Completely redone patent section. Dates of FDA approval, patent expiration, and exclusivity expiration are now included.
- Column headings now appear at the top of each page for easier viewing.
- Database is now available in five sorted versions as listed above.

Version 2.3 (10/26/02): 333 drugs, 26 companies, partial Q3 2002 results
- 55% more drugs and 63% more companies than prior version.

Version 2.2 (04/26/02): 215 drugs, 16 companies, complete Q1 2002 results

Version 2.1 (03/07/02): 215 drugs, 16 companies, complete Q4 2001 results

Version 2.0 (02/14/02): 112 drugs, 16 companies, complete Q4 2001 results

Version 1.0
(01/02/02): 87 drugs, 11 companies, complete Q3 2001 results

 

Major Drug Database and Other Download Links

Below you can find the latest updates to the major drug database that I have been working on.
Please note that the files are in PDF file format. If you do not have Adobe Acrobat Reader, you can download it HERE:

New Feature!! Statin Market Share

Statin Drug Class Price Comparison

Major Drug Database Version 3.1 (Build Date: April 6, 2003) Sorted By Company
Major Drug Database Version 3.1 (Build Date: April 6, 2003) Sorted By Drug Brand Name
Major Drug Database Version 3.1 (Build Date: April 6, 2003) Sorted By Chemical Compound Name
Major Drug Database Version 3.1 (Build Date: April 6, 2003) Sorted By Organ System/Use
Major Drug Database Version 3.1 (Build Date: April 6, 2003) Sorted By FY 2002 Sales

Please check out the FAQ link at the top of the page if you have questions about the database.

If you enjoy the information provided, please consider lending your support and help me make the database even better through one of the sites below:

Click Here to Pay Learn More Amazon Honor System

     


Comments? Questions? Suggestions?

As always, comments and suggestions are welcome. Please send your comments to me at HERE or sign the guestbook. If you would like to be notified of updates to the database or this page, you can also email me to be added to the mailing list. I've also added a GuestMap. Since this the World Wide Web, I'm interested in seeing who visits this page so please take a moment to put a pin where you're located and see who else has been to the webpage.

 

   

Please note that I have spent a lot of time working on this. Some people in the past have taken my work and claimed it as their own which is why I do not offer the Excel file format at this time. If this happens again, downloads will not be allowed again.

Suggested Reading

Some of my favorite finance and investing related books that I own. Reviews will be coming soon. First, some serious books on investing philosophy followed by some lighter but still very educational books:

cover

$89.95      $62.97
Investment Valuation: Tools and Techniques for Determining the Value of Any Asset by Aswath Damadoran  

 

cover

$25.00     $17.50
Lessons from the Legends of Wall Street: How Warren Buffett, Benjamin Graham, Phil Fisher, T. Rowe Price, and John Templeton Can Help You Grow Rich by Nicki Ross

cover

$25.00
The Essays of Warren Buffett : Lessons: Lessons for Corporate America by Warren E. Buffett  and Lawrence A. Cunningham

 

cover

$14.00     $11.20
One Up on Wall Street: How To Use What You Already Know To Make Money In the Market by Peter Lynch and John Rothchild

cover 

$29.95     $20.97
A Random Walk Down Wall Street by Burton Gordon Malkiel

 

cover

$30.00     $21.00
The New Buffettology: The Proven Techniques For Investing Successfully In Changing Markets That Have Made Warren Buffett The World's Most Famous Investor by Mary Buffett

cover

$39.95      $27.97
Common Stocks and Uncommon Profits and Other Writings by Philip A. Fisher

cover

$27.00     $18.00
The Gorilla Game - Picking Winners in High Technology by Geoffrey Moore, Paul Johnson and Tom Kippola

cover

$24.95     $17.47
Everything I Know About Business I Learned From Monopoly by Alan Axelrod

cover

$24.95    $17.47
Dilbert and The Way Of The Weasel by Scott Adams

 
Search:
Keywords:
In Association with Amazon.com
 

Amazon.com will donate a small portion of each sale from any of the above links to the running and maintenance of this site. There is no extra charge to you. Please consider using them for your holiday shopping.

 Counter

Page created on October 26, 2002
Page Last edited on April 17, 2003

 

Hosted by www.Geocities.ws

1